找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Diabetes and Kidney Disease; Edgar V. Lerma,Vecihi Batuman Book 2022Latest edition Springer Nature Switzerland AG 2022 diabetic nephropath

[復(fù)制鏈接]
查看: 36229|回復(fù): 59
樓主
發(fā)表于 2025-3-21 18:07:09 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書(shū)目名稱Diabetes and Kidney Disease
編輯Edgar V. Lerma,Vecihi Batuman
視頻videohttp://file.papertrans.cn/271/270421/270421.mp4
概述Emphasizes a practical clinical approach for general clinicians managing patients with diabetes.Includes a beneficial summary of current clinical and basic research relevant to clinical practice.Featu
圖書(shū)封面Titlebook: Diabetes and Kidney Disease;  Edgar V. Lerma,Vecihi Batuman Book 2022Latest edition Springer Nature Switzerland AG 2022 diabetic nephropath
描述This book provides a concise yet comprehensive resource on Diabetic Kidney Disease. Similar to the previous edition, the book reviews the most up-to-date research on diabetic nephropathy, the current understanding of its pathophysiology, renal structural alterations and clinical features, and summarizes recent evidence-based clinical treatment modalities for the prevention and management of diabetic kidney disease. General clinical aspects are also covered, as well as an overview to the novel approaches being designed by leading researchers in the field..A convenient compendium for physicians involved in the care of diabetic patients with varying degrees of kidney involvement,?.Diabetes and Kidney Disease, 2e.?is also a handy resource for medical residents and students interested in the current status and future approaches to reducing the burden of diabetes and diabetic kidney disease..
出版日期Book 2022Latest edition
關(guān)鍵詞diabetic nephropathy; glycemic control; novel treatments; hypertension; cardiovascular disease
版次2
doihttps://doi.org/10.1007/978-3-030-86020-2
isbn_softcover978-3-030-86022-6
isbn_ebook978-3-030-86020-2
copyrightSpringer Nature Switzerland AG 2022
The information of publication is updating

書(shū)目名稱Diabetes and Kidney Disease影響因子(影響力)




書(shū)目名稱Diabetes and Kidney Disease影響因子(影響力)學(xué)科排名




書(shū)目名稱Diabetes and Kidney Disease網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱Diabetes and Kidney Disease網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱Diabetes and Kidney Disease被引頻次




書(shū)目名稱Diabetes and Kidney Disease被引頻次學(xué)科排名




書(shū)目名稱Diabetes and Kidney Disease年度引用




書(shū)目名稱Diabetes and Kidney Disease年度引用學(xué)科排名




書(shū)目名稱Diabetes and Kidney Disease讀者反饋




書(shū)目名稱Diabetes and Kidney Disease讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

0票 0.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

1票 100.00%

Disdainful Garbage

您所在的用戶組沒(méi)有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 21:26:34 | 只看該作者
板凳
發(fā)表于 2025-3-22 04:12:31 | 只看該作者
地板
發(fā)表于 2025-3-22 05:00:09 | 只看該作者
Cardiovascular Disease and Diabetic Kidney Diseasemechanisms. The prevention of CVD onset can mitigate morbidity and mortality from its complications, specifically with comorbid diabetes, CKD, and DKD. In consideration of these factors, this chapter highlights new developments in epidemiology and therapy in CKD, specifically DKD, and CVD with an emphasis on recent major CVD outcome trials.
5#
發(fā)表于 2025-3-22 09:48:01 | 只看該作者
Soziologische Diskriminierungsforschung have been shown through multiple clinical trials to slow the progression of chronic kidney disease and are also discussed here..Diabetes is still the most common cause of end-stage renal disease in Western countries, and research highlighting their overall success in treating diabetes and its major complications are presented.
6#
發(fā)表于 2025-3-22 16:40:56 | 只看該作者
7#
發(fā)表于 2025-3-22 18:44:54 | 只看該作者
Thomas Hinz,Katrin Auspurg,Andreas Schneckminuria range. Although GFR can be within normal range early in this phase, it continues to decline as the stage progresses. Lastly, stage 5 is called end-stage renal disease (ESRD) or uremia. This stage is due to advanced diabetic nephropathy and requires initiation of renal replacement therapy for survival.
8#
發(fā)表于 2025-3-22 23:41:33 | 只看該作者
https://doi.org/10.1007/978-3-476-00512-0albuminuria-proteinuria. Prevention or minimization of albuminuria delays the progression of kidney disease as well as CVD. Combination of an ACE-I and an ARB is not recommended. Many new drugs that target protecting or preserving glomerular podocytes are currently being evaluated.
9#
發(fā)表于 2025-3-23 01:25:13 | 只看該作者
Soziologie der Sucht und ihrer Geschichteapter reviews the prevalence, cause and clinical consequences of anemia, the benefits and risks of treatment and provide insight into anemia management based on clinical trial in patients with diabetes and kidney disease.
10#
發(fā)表于 2025-3-23 09:15:19 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-23 02:15
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
霸州市| 额尔古纳市| 阿城市| 沁源县| 石柱| 晴隆县| 广宁县| 离岛区| 应用必备| 芦溪县| 定安县| 巫溪县| 安图县| 三江| 萨嘎县| 天气| 临泉县| 呈贡县| 郯城县| 卢龙县| 珲春市| 崇州市| 宁乡县| 灌南县| 南丹县| 龙南县| 余江县| 甘德县| 资兴市| 前郭尔| 邻水| 星子县| 响水县| 乌鲁木齐县| 恭城| 赤水市| 镇沅| 论坛| 宁阳县| 含山县| 全州县|